Skip to content

Comparison of a standard 19-gauge needle and a new 19-gauge histology needle in diagnostic yields of endoscopic ultrasound-guided fine needle aspiration for solid tumors. Multicenter prospective randomized controlled study

Comparison of a standard 19-gauge needle and a new 19-gauge histology needle in diagnostic yields of endoscopic ultrasound-guided fine needle aspiration for solid tumors. Multicenter prospective randomized controlled study - 19-gauge histology needle vs 19-gauge standard needle in EUS-FNA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012177
Enrollment
110
Registered
2013-11-01
Start date
2013-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid tumor

Interventions

first pass:A standard 19-gauge FNA neelde 2nd pass:A new 19-gauge histology FNA needle first pass:A new 19-gauge histology FNA needle 2nd pass:A standard 19-gauge FNA neelde

Sponsors

First Dept. of Internal Medicien, Gifu University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with a solid mass which is measured more than 20mm and located around upper intestine on imaging studies 2)Patients who understand and willing to give a written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients with bleeding tendency or patients who cannot stop taking antiplatelet agents or anticoagulant agents 2) PS of more than 4 3) possible pregnancy 4) Age<20 5) Patients who are judged inappropriate by a assigned physician

Design outcomes

Primary

MeasureTime frame
Accuracy in histological analysis

Secondary

MeasureTime frame
Yield of visible core Yield of core specimen on histological analysis Success rates of FNA Complication rate of EUS-FNA

Countries

Japan

Contacts

Public ContactIchiro Yasuda

Gifu University Hospital First Dept. of Internal Medicine

takuji@w7.dion.ne.jp058-230-6308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026